When four to six months of dedicated physical therapy, splinting, and orthotics fail to deliver relief, orthopedic specialists escalate to interventional procedures. Corticosteroid injections into the plantar fascia insertion offer powerful, rapid suppression of localized inflammation. However, repeated steroid administration carries documented risks, including atrophy of the protective plantar fat pad and structural rupture of the fascia aponeurosis. Consequently, clinicians limit steroid injections to one or two cycles, often preferring platelet-rich plasma (PRP) injections to stimulate endogenous collagen remodeling.
Extracorporeal Shockwave Therapy (ESWT) represents an intermediate non-invasive bridge before surgery. Delivering focused acoustic shockwaves into the painful heel stimulates local blood circulation, metabolizes pain-signaling substance P, and triggers controlled cellular repair within recalcitrant scar tissue. Success rates across clinical trials range between 65% and 80% for chronic cases that resisted standard conservative care.
Direct bone spur removal surgery remains a strictly reserved option. Surgical intervention, either an open plantar fasciotomy with calcaneal ostectomy or an endoscopic procedure, is considered only after 12 months of persistent, debilitating symptoms. Surgeons release a portion of the plantar fascia band to release tension and mechanically grind down the bony spur. Because altering foot architecture alters gate dynamics and introduces long recovery intervals, conservative interventions remain the undisputed gold standard for over 95% of patients.
